LINACORT-6 Tablets

LINACORT-6 Tablets – Corticosteroid Therapy

LINACORT-6 contains **Deflazacort 6 mg**, a glucocorticoid indicated for the treatment of inflammatory and autoimmune conditions where suppression of inflammation and immune response is required.

Scientific Rationale

Inflammatory and immune-mediated disorders involve excessive immune activation and release of inflammatory mediators. Deflazacort provides effective anti-inflammatory and immunosuppressive action with comparatively lower effects on electrolyte balance.

Mechanism of Action

Deflazacort inhibits the release of pro-inflammatory cytokines and mediators, reducing inflammation, tissue swelling and immune-mediated damage.

Indications and Benefits

Allergic and inflammatory conditions.
Respiratory disorders with inflammatory component.
Autoimmune and immunological disorders, as advised by physician.
Conditions requiring short- or medium-term corticosteroid therapy.

Dosage

To be taken strictly as directed by the physician. Dose and duration depend on clinical condition and patient response.

Safety Information

Use under medical supervision only.
Abrupt discontinuation should be avoided.
Long-term use requires regular medical monitoring.
Not intended to replace medical advice.

LINACORT-6 provides reliable corticosteroid therapy with a well-established safety profile when used appropriately.